INTHEMA
Unknown
2,000 enrolled
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
Unknown
1,000 enrolled
Is Ibrutinib-related Atrial Fibrillation Dose Dependent
Unknown
18,000 enrolled
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD
Phase NA Unknown
108 enrolled
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
Unknown
40 enrolled
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
Phase 2/3 Unknown
30 enrolled
COVIDVAC OH
Unknown
500 enrolled
DLI-Boost
Phase 3 Unknown
52 enrolled
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
Unknown
320 enrolled
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
Unknown
350 enrolled
Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence
Phase NA Unknown
30 enrolled
Adherence, Viability, Clinical Evolution and Therapeutic Efficacy in Patients Undergoing Bone Marrow Transplantation
Phase NA Unknown
93 enrolled
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation
Unknown
100 enrolled
Sexual Health in Patients With Hematologic Malignancies
Phase NA Unknown
110 enrolled
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies
Unknown
100 enrolled
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation
Unknown
300 enrolled
A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors
Phase 3 Unknown
168 enrolled
Oral Complications in Hematological Malignancies
Unknown
100 enrolled
Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation
Phase NA Unknown
100 enrolled
Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors
Phase 2 Unknown
20 enrolled
CReSCT
Phase NA Unknown
370 enrolled
The Effect of Lavender Oil on Fatigue and Sleep Quality
Phase NA Unknown
100 enrolled
Effectiveness of Extraoral Photobiomodulation in Management of Oral Adverse Effects in Patients Undergoing HSCT
Phase NA Unknown
42 enrolled
PBT
Unknown
80 enrolled
CAR T-CELL Therapy Educational Video Trial
Phase NA Unknown
80 enrolled
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
Phase 1/2 Unknown
181 enrolled
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management
Unknown
3,000 enrolled
Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell Transplantation
Phase NA Unknown
36 enrolled
Mindfulness-based Virtual Reality Intervention
Phase NA Unknown
110 enrolled
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome
Phase 2 Unknown
50 enrolled
COVID19-hematological Malignancies: the Italian Hematology Alliance
Unknown
250 enrolled
The Association of Microbiota Composition With cGVHD After Allo-HSCT
Unknown
300 enrolled
KTcCHO
Unknown
100 enrolled
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
Phase 3 Unknown
340 enrolled
Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)
Phase 3 Unknown
50 enrolled
HCP
Phase NA Unknown
40 enrolled
IPPACTTO
Phase NA Unknown
396 enrolled
Symptom Clusters in Hong Kong Chinese Children With Blood Cancer
Unknown
120 enrolled
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
Phase 1/2 Unknown
30 enrolled
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System
Unknown
600 enrolled
Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Unknown
60 enrolled
ESAAC
Phase NA Unknown
800 enrolled
Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation
Phase 1/2 Unknown
56 enrolled
THERMAL
Unknown
20 enrolled
Analysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed Individuals
Unknown
3,270 enrolled
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
Phase 2/3 Unknown
180 enrolled
Haplo-CIK
Phase 1/2 Unknown
20 enrolled
Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT
Phase 2 Unknown
50 enrolled
NIVALLO
Phase 2 Unknown
14 enrolled
GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide
Phase 1/2 Unknown
47 enrolled